Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06647836
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
None
First Post:
2024-09-11
Brief Title:
The Therapeutic Effect of Immunotherapy in Patients With Advanced Lung Squamous Carcinoma
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Exploration of the Treatment Trajectory and Drug Resistance Mechanism of Immunotherapy Combined With Chemotherapy in Patients With Advanced Lung Squamous Carcinoma
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this observational study is to investigate the treatment trajectory of immunotherapy in patients with squamous non-small cell lung cancer sq-NSCLC The primary objective is to identify potential indicators that can predict the efficacy of immunotherapy and explore strategies to prolong its effectiveness in sq-NSCLC patients Biological specimens and medical imaging data will be collected from patients already receiving immunotherapy as a first-line treatment and follow-up will be conducted to analyze prognosis based on different patterns
Detailed Description:
The medical imaging data will be collected retrospectively and prospectively and the blood samples and tumor tissues will be collected prospectively
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None